E-drug: Generic substitution
-------------------------------------------------------------------------
Dear colleagues,
A lot of intervention studies have been done looking at promoting
prescribing by using generic names (INN, BAN). I am interested in
looking at how promoting generic substitution at dispensing level
impacts on drug use and treatment costs and the legal implications (If
any) of doing so. Is generic substitution at dispensing level easier to
implement than generic prescribing?
I would appreciate any input form you colleagues on this subject. I
would also be interested to get links to any studies that have been
done on generic substitution, especially not in government health
sectors.
Please send me any studies or links and your comments/
observations directly on my email below.
Thank you,
Dr Atieno Ojoo
Chief Pharmacist
Gertrude's Garden Children's Hospital
P O Box 42325-00100
GPO, Nairobi
Tel 254 2 3763474-7
Fax 254 2 3763281
Email: atisojoo@yahoo.co.uk
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug